| Followers | 2543 |
| Posts | 250731 |
| Boards Moderated | 34 |
| Alias Born | 05/06/2014 |
Tuesday, September 19, 2017 9:36:07 PM
The trial will be a two-armed, with approximately 250-patients enrolled and with approximately 125 patients in each arm. It will be conducted in the U.S. with possible study sites in Europe. Currently, we are working on gathering all the items the FDA requires from us before submitting the IND application. Once the IND and clinical trial are approved, we will begin the process of screening patients to participate.
(See pg. 27 of MicroCap Review for our recent feature)
http://www.microcapreview.com/issues/?utm_source=Facebook&utm_campaign=MicroCap
investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/
Recent PMCB News
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
